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AUTOIMMUNE THYROIDITIS 
• Auto immune thyroiditis is the condition where the immune system 
attack normal thyroid tissue. 
• Hashimoto’s thyroiditis or diffuse lymphocytic auto immune thyroiditis is 
the common form. 
• It is the most common form of thyroiditis as well as most common cause 
of hypothyroidism in iodine sufficient areas.  
• It is first described by a japanese surgeon Dr.Hakaru hashimoto in 1912. 
• He coined the term struma lymphomatosa to the condition. 
• The disease is characterised by pathological changes like lymphocytic 
infiltration, fibrosis, loss of follicular epithelium. 
• The lymphocytic infiltration is a slow process so the symptoms of the 
disease may appear very late. 
• The types of auto immune thyroiditis include goitrous thyroiditis, 
atrophic thyroiditis, juvenile thyroiditis, postpartum thyroiditis, silent 
thyroiditis, and focal thyroiditis. 
• Goitrous form of auto immune thyroiditis is known as the hashimoto’s 
thyroiditis. 
• Its incidence is more among women than men.  
                                       
TYPES OF AUTO IMMUNE THYROIDITIS 
• Goitrous thyroiditis – manifest as swelling of thyroid gland with 
lymphocytic infiltration, fibrosis, thyroid cell hyperplasia. 
• Atrophic thyroiditis – also known as primary myxedema. Usually 
manifest as atrophy and fibrosis of the thyroid gland. 
Both of them have a chronic course. 
• Juvenile thyroiditis – shows lymphocytic infiltration. The disease have a 
chronic course but may disappear later during the life. 
• Post partum thyroiditis – it shows a transient course and present as a 
small goiter with lymphocytic infiltration. 
• Silent thyroiditis – painless thyroiditis with transient course. manifest as 
a small goiter and lymphocytic infiltration. 
• Focal thyroiditis – can show a progressive course. It is present in thyroid 
gland of 20% of people at autopsy. 
Eventhough the course and presentation of these types may vary the 
etiopathogenesis of each remain almost same. 
A combination of genetic, hormonal, environmental, and other factors are 
responsible for the pathogenesis behind each of the auto immune thyroiditis 
forms mentioned above. 
   
                                       
INCIDENCE and PREVALENCE 
 Annual incidence of auto immune thyroiditis is 4/1000 women and 
1/1000 men. 
 Japanese  populations most commonly affected. 
 In those [japan] regions, genetic factors and chronic exposure to high 
iodine diet are important risk factors for auto immune thyroiditis. 
 Sub clinical hypothyroidism found in 6-8% of women and 3% of men. 
 Sub clinical hypothyroidism with auto antibodies transformed into 
hypothyroidism is about 4%. 
 Mean age group of auto immune thyroiditis 30-50 years . 
 
AUTO IMMUNE THYROIDITIS IN INDIA 
Studies conducted in indian population regarding auto immune thyroiditis 
shows that 16.7% of adults are having anti TPO antibody and about 12.5% have 
anti thyroglobulin antibodies. Studies conducted among the school going 
female students shows that  7.5% are juvenile auto immune thyroiditis which 
include both hashimoto’s thyroiditis and focal lymphocytic thyroiditis. Further 
FNAC studies done among them shows that 15% of them are having 
subclinical hypothyroidism and 6.5% are having overt hypothyroidism.  
                                       
 ETIOLOGY 
• The causes of hashimoto’s thyroiditis are multifactorial. Family 
history among the hashimoto’s thyroiditis patients suggest that it has 
a genetic predisposition and the higher incidence of the disease 
among women of perimenopausal age group suggest that it has also 
connection with some sex hormones. 
• Pre existing auto immune conditions like type 1 diabetes mellitus, 
addison’s disease etc are some of the risk factors for the 
development of hashimoto’s thyroiditis. 
• Environmental factors like infection, iodine, smoking, pregnancy, 
stress etc also play some role in the etiopathogenesis of autoimmune 
thyroiditis. 
• Postpartum autoimmune thyroiditis can be resulted due to the 
effects of hormones or it can be due to intra thyroidal fetal 
microchimerism. Fetus can initiate an intra thyroidal allo immune 
reaction and which can precipitate autoimmune thyroiditis in 
pregnant women. 
                                       
• Treatment with interferon gamma, IL-2 for  cancer or hepatitis can 
cause worsening of the autoimmune process in person with existing 
subclinical autoimmune thyroiditis.  
    CLINICAL PRESENTATION 
    Hashimoto’s thyroiditis can clinically present as symptoms associated 
with two primary complications of the disease – diffuse goiter and 
hypothyroidism. Rarely in some cases initially hyperthyroidism can 
develop which later become hypothyroidism as the disease progress. 
Sometimes the diffuse goiter presentation can be associated with 
euthyroid state also. So the exact diagnosis and identification of the 
disease and its clinical presentation are necessary for the treatment of 
the disease and better prognosis. 
     On diffuse goiter presentation the swelling is firm, lobulated with varying 
sizes. The lobulated appearance may be misdiagnosed as a multi nodular 
goiter. As the size of the goiter increases it can cause pressure symptoms 
such as dyspnoea, dysphagia, hoarseness of voice etc. 
     Sometimes the swelling can be painful due to increased blood flow to the 
thyroid gland. This can be misdiagnosed as a thyroid lymphoma.  
                                       
 PATHOGENESIS 
    After an insult in susceptible individuals tolerance of cells to the t 
lymphocytes is lost and  an  auto immune process triggers. Thyroid 
specific auto antigens are presented to the antigen presenting cells by 
the thyrocytes. The thyroglobulin produced in the thyroid tissue has a 
major role in the pathogenesis of autoimmune thyroiditis. Thyroglobulin 
possess almost 40 epitops and in autoimmune thyroiditis patients these 
epitope recognition patterns show some alterations from the  normal 
individual. Thyroid peroxidase enzyme also has significant role in 
pathogenesis because studies have showed that almost 180 auto 
antibodies are present against TPO enzyme and they cause more 
immunological damage to the thyroid tissue than other auto antibodies. 
Lymphocytic infiltration of the gland occurs in central stages of the 
disease. 
      Finally the glandular cells are destructed by the cytotoxic activity of the 
T cells, apoptotic activity of the antibodies produced from B lymphocytes 
and cytokine activity produced by the macrophages. Finally the patient  
develop hypothyroidic features. 
                                       
INVESTIGATIONS 
• Thyroid function tests (TFT)  
• anti TPO antibodies are positive. 
• FNAC – shows presence of hurthle cells. 
THYROID FUNCTION TEST 
The hormone levels produced by the thyroid and pituitary glands are 
estimated in this test. TSH, free T4, free T3 values are determined and the 
thyroid status of the patient is detected. So treatment can be given based 
on the thyroid status. 
Anti TPO antibody test 
This is an antibody test where the presence of anti TPO antibodies in the 
blood is detected. Its presence in blood confirms the diagnosis of 
hashimoto’s thyroiditis. 
FNAC OF THYROID  
FNAC and further staining study of the sample shows heterogenous 
lymphocytic infiltrations and presence of hurthle cells.  
                                       
   TREATMENT 
Thyroid hormone replacement therapy 
Synthetic thyroid hormones or natural extracts containing thyroid 
hormones can be used for treatment of hashimoto’s thyroiditis. 
Synthetic thyroid hormones are levonyl, synthroid, levothroid etc. 
Natural extracts containing thyroid hormones are produced from the pigs. 
Ex: Armor thyroid which contain both levo thyroxine and tri iodo thyronine. 
PROGNOSIS 
Excellent prognosis with early diagnosis and proper treatment. 
PREVENTION 
Since it is an auto immune disorder it is difficult to prevent and till now no 
effective prevention method is discovered.  
 
                                       
 
 
AIM OF THE STUDY 
 
 
 
                                       
 
 
AIM AND OBJECTIVES 
 
1. To study the frequency of auto immune thyroiditis, mode of 
presentation, to determine the age and sex incidence.  
2. To find out the correlation between auto antibodies, thyroid 
hormones, and cytological features in auto immune thyroiditis 
patients. 
 
 
                                       
 
 
 
 
REVIEW OF LITERATURE 
 
 
                                       
  THYROID GLAND  
     Thyroid gland is a butterfly shaped gland located in the anterior part of 
neck and  consists of two lobes – right and  left lobes those are 
connected together by a small lobe called the isthumus. A third lobe 
called pyramidal lobe may project from the isthumus. Sometimes a 
fibromuscular band known as levator glandulae thyroidae  is seen in 
some individual from hyoid bone to the pyramidal lobe or isthumus. 
  
                                       
   SITUATION 
      Thyroid gland is situated against C5,C6,C7 and T1 vertebrae. each lobe 
extend from middle of thyroid cartilage to the fourth or fifth tracheal 
ring. Isthumus extend from second tracheal ring to fourth tracheal ring.  
MEASUREMENTS 
    One lobe almost  5x2.5x2.5 cm in size. isthumus around 1.2x1.2 cm.      
thyroid gland weighs about 25grams. size of the thyroid is larger in females 
than males. during the periods of menstruation and pregnancy the gland 
may increase in size. 
  CAPSULES OF THYROID GLAND 
     It has two capsules-a true and false capsules. 
     True capsule – formed by the condensation of the outer connective 
tissue of the gland. Deep to the true capsule a capillary plexus is seen. 
     False capsule – formed from the pre tracheal layer of the deep cervical 
fascia. It forms a ligament known as suspensory ligaments of berry that 
connect the gland to the cricoid cartilage. 
                                       
 
PARTS OF THYROID GLAND 
Each lobe possess – an apex, a base, three surfaces – lateral, medial, 
posterolateral and two borders -  anterior and posterior. 
ARTERIAL SUPPLY 
    Thyroid gland is supplied by the superior and the inferior thyroid 
arteries. 
    Superior thyroid artery is the first anterior branch  
    of external carotid artery. It divides into anterior and posterior branches 
at the upper pole of thyroid gland. 
    One side anterior branch anastamose with the same of the opposite side 
and the posterior 
    branch anastamose with the ascending branch of               
    inferior thyroid artery. 
                                       
    Inferior thyroid artery is a branch of subclavian artery from the thyro 
cervical trunk. It divides into four to five glandular branches. 
    Tracheal and esophageal arteries give rise to some accessory thyroid 
arteries that also supplies the thyroid gland. 
VENOUS DRAINAGE 
  Superior, middle, and inferior thyroid veins perform the major venous 
drainage from the thyroid gland. 
    Superior thyroid vein drains the upper portion and joints with the internal 
jugular vein. 
    Middle jugular vein also joints with the internal jugular vein. 
    Inferior thyroid veins drains from lower portions of thyroid and enters left 
brachiocephalic vein. 
    Kocher’s vein – 4
th
 thyroid vein seen in some individual. 
  LYMPHATIC DRAINAGE 
    Lymphatic drainage from upper portions of the gland goes to deep 
cervical lymph nodes. 
                                       
    Lymphatics from lower portions of the gland drains to lower deep cervical 
lymph nodes. 
NERVE SUPPLY 
    Major nerve supply derives from middle cervical ganglia. superior and 
inferior cervical ganglia also take part in nerve supply to thyroid gland. 
     Para sympathetic fibers derived from vagus nerve. 
 
 
                                       
HISTOLOGY OF THYROID GLAND 
Histologically it consists of two type of cells – follicular and parafollicular 
cells. Follicular cells secretes T3 and T4. The lining epithelium of the 
follicular cells are columnar during secretary phase and cuboidal during 
inactive phase. The follicular cells store its secretions as colloid inside it. 
Thyroid also contain parafollicular cells or C cells which are distributed in 
between the follicular cells. They secrete calcitonin hormone which has 
role in calcium metabolism.  
       
 
                                       
DEVELOPMENT OF THYROID GLAND 
Thyroid gland develop from a structure known as the median endodermal 
thyroid diverticulum. This diverticulum grows downwards from the floor of the 
primitive pharynx caudal to tuberculum impar. 
Thyroid gland is formed by the enlargement of the lower end of the 
diverticulum. The remaining part of the diverticulum remains as a narrow 
structure known as the thyroglossal duct. 
Upper end of diverticulum is represented by the foramen caecum of the 
tongue and the lower end is represented by the pyramidal lobe. 
The thyroid gland become functioning from the third month of development. 
 
                                       
THYROID – PHYSIOLOGY 
    The follicular cells of the thyroid gland secrete tri iodo thyronine (T3) 
and tetra iodo thyronine (T4 or thyroxine). They regulate the basal 
metabolic functions of the body. T3 and T4 secretions are regulated by 
the thyroid stimulating hormone (TSH) produced from the anterior 
pituitary gland. Para follicular cells of the thyroid gland secrete another 
one hormone called calcitonin. It regulate the calcium metabolism of the 
body. 
     About 93% of the active hormone secreted by the thyroid is thyroxine 
and remaining 7% is tri iodo thyronine. But in the tissues most of the T4 
secreted are converted to tri iodo thyronine. So both of these are 
functionally important. 
     Both the hormones have almost same functions but the rate and 
intensity of the activities differs. Tri iodo thyronine is almost four times 
more potent than thyroxine but its half life and concentration in blood 
are less.  
     CALCITONIN – it is a peptide hormone secreted by the para follicular cells 
of thyroid. Its function is to reduce plasma concentration of calcium. 
                                       
SYNTHESIS AND SECRETION OF THYROID 
HORMONES  
IODINE REQUIREMENT 
     The first step of thyroid hormone synthesis starts from the transport of 
iodides from the blood into the thyroid cells and follicles. This is process 
known as IODIDE TRAPPING.  
     Iodide trapping is done by the basal membrane of the cells of the thyroid 
gland which shows 250 times greater ability than other cells for thyroid 
transport. 
     A very important factor which regulate the rate of the iodide trapping is 
TSH concentration. 
   TSH stimulates the activity of the thyroid pump in the thyroid cells. 
Specific membrane receptors called TSH receptors are present in thyroid 
cells for its functioning. The TSH receptor is G protein coupled receptor. 
 
 
                                       
STEPS OF SYNTHESIS  
1. Iodide trapping 
2. Thyroglobulin formation and secretion 
3. Oxidation of the iodide ion 
4. Iodination of thyronine and formation of thyroid hormones 
5. Storage of thyroglobulin. 
 
     
                                       
THYROGLOBULIN FORMATION 
The endoplasmic reticulum and the golgi apparatus of the thyroid cells 
produce a large molecular weight glycoprotein called THYROGLOBULIN. 
Tyrosine amino acid is an essential substrate for the production of 
thyroglobulin. Each molecule of thyroglobulin contain almost 70 tyrosine 
amino acids. 
The thyroxine and the tri iodo thyronine are almost an integral part of 
the thyroglobulin molecule during synthesis and during storage also. 
    OXIDATION OF THE IODIDE ION 
    The trapped iodides are oxidised at the apical membrane of the thyroid 
gland with the help of a peroxidase enzyme and hydrogen peroxide to 
nascent iodine ( oxidised iodine ). 
 IODINATION OF TYROSINE  
     Iodination of tyrosine is also known as organification of thyroglobulin. 
     one molecule of oxidised iodine is added to thyroglobulin to produce 
mono iodo thyronine and then one more molecule is added to form di 
                                       
iodo thyronine. Then one di iodo thyronine get coupled with mono iodo 
thyronine or another one molecule of di iodo thyronine to produce tri 
iodo thyronine or thyroxine respectively. 
     This is a slow process but it is activated by an enzyme iodinase present in 
the thyroid cells. 
     The major hormonal product of the coupling reaction is the thyroxine. 
    Both thyroxine and tri iodo thyronine remains as a part of the 
thyroglobulin molecule itself. 
STORAGE OF THYROGLOBULIN 
    Thyroid gland is capable of storing huge amount of T3 and T4 after 
production for future body requirements.    
    RELEASE OF T4 AND T3 
    The apical surface of the thyroid cells forms pinocytic vesicles around 
the colloid of follicular cells by a pseudopod extension. Then lysosomes 
of cytoplasm immediately fuse with these vesicles. Proteases present in 
the lysosomes degrade the thyroglobulin molecule and release T4 and 
T3 in free form. Free T4 and T3 diffuses from thyroid cells to the 
                                       
sorrounding capillaries. Thus the thyroxine hormones reaches the blood. 
About 93% is T4 and remaining is T3. But in the tissues about half of the 
T4 is deiodinated to additional tri iodo thyronine. So the tissues mainly 
uses tri iodo thyronine.   
TRANSPORT OF T4 AND T3 
    When released into blood T4 and T3 bind with plasma proteins like 
thyroid binding globulin and thyroid binding pre albumin. T4 shows 
greater affinity and T3 shows lesser affinity to these plasma proteins. So 
T4 is delivered slowly and T3 is delivered rapidly to the tissues. Inside the 
tissue cells also T4 shows more affinity to bind with the intra cellular 
proteins. So T3 is used up very early by the tissues and T4 is stored for 
longer duration. 
    Since the thyroid hormones show affinity to intracellular proteins they 
are having long latent period of action (slow onset and longer duration 
of action). The actions of T3 occur about 4 times rapidly than T4 with a 
latent period of 6 to 12 hours and peak cellular activity with in 2 to 3 
days. 
 
                                       
COMPARISON BETWEEN T4 AND T3 
T4 T3 
Thyroid secretes more amount of 
T4(tetra iodo thyronine). 
Secrete less amount of T3(tri iodo 
thyronine) when compared to T4. 
More tightly bound to plasma 
protein.so it is the circulating form. 
Less tightly bound to plasma 
protein. so less circulation. 
Slow acting form. Peak effect only 
after 6 to 8 days. 
T3 is five times more potent than 
T4. So faster action. 
Less bound to nuclear receptors. 
T4 receptor complex is unable to 
activate or depress the gene 
transcription. 
More avidly bound to nuclear 
receptors. So this complex can 
regulate transcription process. 
One third of T4 is converted to T3 
in thyroid, liver, kidney by the type 
1 deiodinase enzyme. So it is the 
secretary form. 
Target cells usually generates T3 by 
type 2 deiodinase enzyme. So it is 
the active form. 
                                       
  FUNCTIONS OF THYROID HORMONES 
1. Increases the transcription of many genes. 
    Thyroid hormones activates nuclear receptors and this increases the rate 
of many transcription processes. 
2. Increases cellular metabolic activity. 
Thyroid hormones increases the size, number and activity of the 
mitochondria. This increases the rate of ATP production and accelerates 
cellular function. 
3. Thyroid hormone increases the Active transport of ions through cell 
membranes by activating Na+ K+ ATPase pump. This can cause increase 
in body heat production. 
4. Effects on growth. 
Growth and development of the brain during the fetal life and initial few 
years of the life are promoted by the thyroid hormones. 
5. Stimulate various carbohydrate metabolism like enhancement of 
absorption from GIT, uptake by cells, glycolysis, gluconeogenesis, 
increased insulin secretion etc. 
                                       
6. Enhancement of fat metabolism. 
7. Plasma levels of cholesterols, phospholipids, triglycerides are decreased 
by thyroxine. 
8. Cholesterol, triglycerides and phospholipid levels are increased by 
thyroxine in liver causing excess fat deposition in liver. 
9. Relative vitamin deficiency occur due to excess thyroxine because of the 
increased activity of many enzymes. 
10. Increased basal metabolic rate. 
11. Increases respiration. 
12. Increased gastro intestinal motility. 
13. Increased thyroid levels can cause nervousness and psycho neurotic 
tendancies. 
14. Increased thyroxine can cause muscle weakness due to excess protein 
catabolism. 
15. Increased levels can cause fine muscle tremors due to increased 
reactivity of the neuronal synapses in the areas of the spinal cord that 
control muscle tone. 
                                       
16. If thyroid excess sleeping difficulty occurs eventhough tiredness is 
present. 
17. Effect on cardio vascular system 
• Blood flow and cardiac output increases. 
• Increased heart rate. 
• Maintain normal arterial pressure. 
• Increased heart strength. 
18. Effect on other endocrine glands 
• Increases insulin secretion by pancreas. 
• Increases para thyroid hormone secretion. 
• Increases ACTH production by pituitary thereby increases 
glucocorticoid secretion by adrenal. 
19. Effect on sexual activity 
• In man – excess thyroxine can cause impotence and decrease can 
cause loss of libido. 
• In women – thyroid hormone abnormalities can cause menstrual 
irregularities. 
                                       
REGULATION OF THYROID HORMONE 
SECRETION 
Thyroid secretion is maintained by some specific feedback mechanisms 
acting via the hypothalamus and anterior pituitary glands. 
   ROLE OF TSH (THYROTROPIN) 
• Increases the proteolysis of the thyroglobulin that has stored in the 
follicles and releases the thyroid hormones to the blood. 
• Activation of iodide trapping mechanism. 
• Increases iodination of tyrosine amino acid. 
• Increases the size and activity of the thyroid cells. 
• Helps in transformation of cuboidal epithelium to secretory columnar 
epithelium. 
 
 
                                       
ROLE OF CYCLIC AMP IN TSH ACTIVITY 
First step of TSH activity is binding with specific TSH receptors on the basal 
membrane surface of the thyroid cells. It activates adenyl cyclase in the 
membrane and this increases the formation of the cyclic AMP inside the 
cell. Cyclic AMP act as a second messenger for the activation of protein 
kinase enzymes. As a result of the activity of protein kinase enzymes 
phosphorylation occur throughout the cells and proteolysis of thyroglobulin 
is achieved and thyroxine and tri iodo thyronine are released. 
ROLE OF TRH IN RELEASE OF TSH  
TRH is the thyrotropin releasing hormone secreted by the hypothlamus. 
Secreted TRH molecules reaches the anterior pituitary through the 
hypothalamo – hypophysial portal blood system. TRH directly increases the 
TSH output from anterior pituitary. The molecular mechanism of this 
process also mediated by the activity of some secondary messengers like 
phospholipase C, calcium ions, diacyl glycerol which eventually leads to TSH 
release. 
 
                                       
FACTORS INFLUENCING TRH RELEASE 
• Exposure to cold can cause increase in secretion of TRH from 
hypothalamus. 
• Various emotional reactions like anxiety, excitement can stimulate 
the sympathetic nervous system and cause decrease in secretion of 
TRH. 
FEED BACK MECHANISAM OF THYROID 
HORMONE SECRETION 
An increase in thyroid hormone levels in body causes reduction of TSH 
secretion from the anterior pituitary. This happens as a direct effect of 
thyroid hormone levels over the anterior pituitary gland itself. This suggest 
the TSH release from anterior pituitary obeys a feed back mechanism. 
 
                                       
 ANTI THYROID SUBSTANCES 
• Thiocyanate ions – decreases the iodide trapping. 
• Propyl thio uracil, methimazole, carbimazole prevent the formation 
of thyroid hormones from iodides and tyrosine. 
• Iodides in higher concentrations can decrease thyroid activity and 
thyroid gland size. 
 
DISORDERS OF THYROID 
1.HYPERTHYROIDISM 
2.HYPOTHYROIDISM 
3.CRETINISM 
 
                                       
HYPERTHYROIDISM 
CAUSES 
• Graves’ disease 
• Auto immune thyroid diseases 
• Hashitoxicosis 
• Toxic adenoma 
• Toxic MNG 
• TSH mediated hyperthyroidism 
In all the above cases the thyroid shows high uptake of  iodine in radio 
iodine uptake study. 
• Subacute thyroiditis 
• Ectopic hyperthyroidism 
• Metastatic follicular thyroid cancer 
• Drugs (amiodarone, excess of iodine) 
These cases show hyperthyroidism with low iodine uptake in radio iodine 
uptake study. 
                                       
In hyperthyroidism the TSH levels are decreased and the thyroid gland 
shows enlargement. 
In autoimmune cases of hyperthyroidism auto antibodies known as thyroid 
stimulating immunoglobulins (TSI) are present in blood. They exert actions 
similar to those of TSH and causes hyperthyroidism. 
SYMPTOMS 
• Higher excitability state 
• Intolerance to heat 
• Increased sweating 
• Weight loss 
• Diarrhoea 
• Muscle weakness 
• Nervousness or other psychic disorders 
• Fatigue and tiredness  
• Inability to sleep 
• Fine hand tremors 
                                       
• Many patients show exophthalmus 
INVESTIGATIONS 
• Serum T3 and T4 are elevated. 
• TSH levels are low in primary thyrotoxicosis. 
• TSH receptor antibodies are elevated in grave’s disease. 
• Radio iodine uptake studies 
• Thyroid ultra sound scanning – can identify nodules. 
MANAGEMENT OF HYPERTHYROIDISM 
• Anti thyroid drugs – propyl thio uracil, methimazole, carbimazole. 
• Radio active iodine – iodine 131 is used in treatment of 
hyperthyroidism. Radio active iodine therapy is contraindicated 
during pregnancy. 
• Surgical therapy 
• Symptomatic treatment – a non selective beta blocker like 
propranalol or nadolol is used for symptomatic treatment. This is 
helpful for controlling symptoms such as such as tachycardia, 
palpitations, tremors. 
                                       
GRAVE’S DISEASE 
Grave’s disease consists of the triad of hyperthyroidism, goiter, 
ophthalmopathy. 
Sometimes a condition known as infiltrative dermopathy or pre tibial 
myxedema can also occur along with grave’s disease. 
CAUSE – auto antibodies are produced by B lymphocytes against TSH 
receptors. These auto antibodies activate the receptors. As a result of this 
thyroid hormone synthesis is increased and hyperthyroidic features 
develop. Genes associated with the pathogenesis of grave’s disease are 
HLA B8, DR3, DR2. 
Immunological activation of fibroblast in extra occular muscles and skin are 
causing accumulation of glycosaminoglycans and results in 
ophthalmopathy and dermopathy. Ophthalmopathy causes lid retraction, 
proptosis and other eye signs of grave’s disease. 
Dermopathy is the accumulation of hyaluronic acid in the dermis. 
Mucinous edema and fragmentation of collagen fibers are the changes 
occuring in skin and producing papules or macules. Pre tibial areas of the 
lower leg is the most commonly affected. 
                                       
THYROTOXIC CRISIS 
Thyrotoxic crisis or thyroid storm is a life threatening condition where the 
thyrotoxic features become very severe and it is a medical emergency. 
PRECIPITATING FACTORS – trauma, infection, radio iodine therapy, sub 
total thyroidectomy in an improperly prepared patients. 
FEATURES 
• Hyper pyrexia 
• Agitation, confusion, psychosis 
• Atrial fibrillation, tachycardia 
• Vomiting, diarrhoea, jaundice, hepatic failure. 
TREATMENT 
• Rehydration  
• Antibiotics 
• Beta blockers – to control sympathetic activity 
• Sodium ipodate, carbimazole 
• Glucocorticoids – reduce conversion of T4 to T3. 
                                       
HYPOTHYROIDISM 
TYPES 
1. Primary hypothyroidism 
2. Secondary hypothyroidism 
3. Thyroid hormone resistance 
       CAUSES OF PRIMARY HYPOTHYROIDISM 
• Chronic auto immune thyroiditis 
• Iatrogenic (after thyroidectomy) 
• Iodine deficiency 
• Drugs like lithium, thionamides, amiodarone 
• Congenital causes like thyroid dysgenesis 
CAUSES OF SECONDARY HYPOTHYROIDISM 
• TSH deficiency 
• TRH deficiency 
Deficiency of the above to regulatory hormones are the major cause. 
                                       
SYMPTOMS 
• Fatigue and sleepiness 
• Muscular weakness 
• Slowed heart rate 
• Increase in body weight 
• Constipation 
• Reduction in cardiac output and blood volume. 
• Mental sluggishness 
• Reduced hair growth 
• Scaliness of skin 
• Voice becomes husky 
• Severe cases produces a generalised edematous condition known as 
myxedema. 
INVESTIGATIONS 
• Serum T4 is low 
• Serum T3 is low 
                                       
• Serum TSH levels are elevated 
MANAGEMENT  
Levo thyroxine is used for the treatment of hypothyroidism. 
Treatment aims the attainment of euthyroid status. 
Dose – 50 to 200 micrograms/day. 
CRETINISM 
Cause – hypothyroidism in fetal life, infancy, or childhood. This can be due 
to congenital lack of thyroid gland (congenital cretinism), or genetic defect 
in thyroid gland which impairs thyroxine production, or iodine lack in the 
diet (endemic cretinism). 
Features – mental retardation and growth retardation. Skeletal growth is 
more inhibited than soft tissue growth. Excessive growth of soft tissues can 
result in obese, short, stocky child. 
Treatment  –  iodine or thyroxine. Treatment should be given with in a few 
weeks of birth. 
 
                                       
GOITRE 
SIMPLE GOITRE 
• Diffuse enlargement of the thyroid. 
• When enlarged follicles filled with colloid it is known as colloid 
goiter. 
• Commonly affects the age group 15 to 25 years. 
• Patient is in euthyroid state and may regress. 
• Endemic goiter – seen in areas of iodine deficiency. So it can be 
prevented by providing adequate amounts of iodine in the diet and 
iodised oil injection once in two years. 
MULTI NODULAR GOITRE 
• Multi nodular enlargement of the thyroid 
• Patient usually present with features of thyrotoxicosis 
 
 
                                       
THYROIDITIS 
Based on duration 
• Acute  
• Sub acute  
• Chronic   
Based on etiology 
• Auto immune – hashimoto’s thyroiditis 
• Granulomatous – de quervains thyroiditis (post viral inflammatory 
response – painful thyroiditis) 
• Fibrosing thyroiditis – Riedel’s thyroiditis 
•  Infective – acute ( bacterial and viral ) 
                               Chronic ( tuberculous, syphilitic ). 
DIAGNOSIS OF THYROID DYSFUNCTION 
1. Thyroid function tests(TFT) 
• Serum TSH – 0.5 to 5 micro units/L  
                                       
• Free T4 – 12 to 28 picomols/L  
• Free T3 – 3 to 9 picomols/L  
• Total T4 – 50 to 150 nanomols/L   
• Total T3 – 1.5 to 3.5 nanomols/L 
TSH – decreased in hyperthyroidism and central hypothyroidism. 
Total T4 – its levels reflect the output from the thyroid gland. 
Total T3 – indicates the peripheral thyroid metabolism. 
Free T4 and T3 – normal in euthyroidism, high in hyperthyroidism and low 
in primary hypothyroidism. 
2. Thyroglobulin level -  <1 to 35 micro grams/L 
3. USG neck – to differentiate the swelling (cystic or solid, SNG or 
MNG) 
4. FNAC – to detect colloid goiter, auto immune thyroiditis and 
malignancy. 
5. Radio active iodine uptake study 
• Normal uptake – 16 to 48% 
                                       
• Hyperthyroidism - >48% uptake 
• Hypothyroidism - <15% uptake 
6. Thyroid scan – a radio active substance that concentrates in thyroid 
is taken orally or given iv and pictures of thyroid are taken using a 
gamma camera. 
7. Uptake of radionuclide increased in  
                 1.Hyperthyroidism 
                 2.Early stages of Hashimoto’s thyroiditis 
            8.Uptake of radionuclide decreased in 
                               1.Hypothyroidism 
                               2.subacute thyroiditis 
 
                                       
AUTO IMMUNE THYROIDITIS 
ETIOLOGY 
• Genetic factors – it shows linkage with HLA class 1 and class 2, 
cytotoxic T lymphocyte associated antigen (CTLA 4 gene), and 
functional polymorphisms of protein tyrosine phosphatase 22 gene  
(PTPN 22 gene). 
• Immunological factors – a pre existing auto immune disorder like 
type 1 diabetes mellitus can be a risk factor for the development of 
hashimoto’s thyroiditis. 
• Environmental factors – infection, iodine, smoking, pregnancy etc. 
ROLE OF THE ETIOLOGICAL FACTORS 
• MHC class 2 genes – they encode products which remove auto 
reactive T cells. 
• CTLA 4 gene – they terminate T cell activation. So any change in this 
gene can cause uncontrolled T cell activation. 
• PTPN 22 gene – codes for a T cell activation inhibitor. 
• Infectious agents – they may produce auto antigens. 
                                       
• Infectious agents can also alter the expression of the surface 
molecules, they can mimic as auto antigens and directly affect the 
immune system. 
• Dietary factors – increased iodides in food can cause enhancement 
of immunogenicity of thyroglobulin, can alter thyroid cell function, 
and forms toxic metabolites with oxygen. Vitamin D deficiency can 
affect T cells and dendritic cells and it may predispose to auto 
immune diseases. 
• Pollutants and toxins like ciggerete smoke, methyl cholanthrene may 
affect T cells and cytokines. 
• Hormones – estrogen enhances the immune responses and 
androgens and gluco corticoids suppress the immune response. 
• Stress – stress can alter the interaction between the neuroendocrine 
system and immune system. So this can be a predisposing factor. 
• Drugs – lithium, interferon alfa, cytokines can potentiate the 
pathogenesis of auto immune thyroiditis. 
• Bone marrow transplantation from an affected donor can cause 
immune reconstitution syndrome and this can favour the 
pathogenesis of auto immune thyroiditis.   
                                       
PATHOGENESIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interaction between genetic 
and non genetic factors  
Antigenic presentation to 
APCs by the thyrocytes.  
T cell and B cell infiltration in 
the thyroid tissue 
T cells causes 
cytotoxicity 
B cells produce 
antibodies against 
TPO enzyme and 
antibody mediated 
destruction of 
thyrocytes occurs 
Macrophages produce 
cytokines. Along with 
antibodies they also 
destruct thyrocytes. 
                                       
Pathogenesis involve the interaction between the genetical, 
immunological, and environmental factors mentioned above. 
• Exposure of genetically predisposed persons to environmental 
factors  
• Invasion of thyroid by antigen presenting cells of MHC class 2 
• This presents the auto antigens against thyroid to the immune 
system for processing 
• The immune system produces auto reactive cells against thyroid 
tissue 
• Formation, clonal expansion, and maturation of auto reactive cells 
and auto antibodies in response to the presented antigen. 
• B lymphocytes produces anti thyroid peroxidase and anti 
thyroglobulin antibodies. 
• Self reactive T cells infiltrate the thyroid gland. 
• CD8+ cytotoxic T cell mediated cell death, CD4+ T cell mediated 
cytokine production(IFN gamma) and further cell death by cytokine, 
binding of anti thyroid antibody and further antibody dependant cell 
death occurs eventually. 
                                       
• At the final stages caspases also cause thyroid destruction. 
THYROID AUTO ANTIBODIES 
• Thyroid peroxidase antibodies – major antibody seen in almost 90% 
patients of auto immune thyroiditis. It is mainly of Ig G type 
antibody. 
• Thyroglobulin antibodies – seen in almost 60% of thyroiditis 
patients and 30% of grave’s disease patients. They are also of 
immunoglobulin Ig G category. 
• Thyroid stimulating hormone receptor antibodies – major auto 
antibody seen in grave’s disease and atrophic thyroiditis. In grave’s 
disease it stimulate TSH receptors and in atrophic thyroiditis it blocks 
TSH receptors. 
• Sodium iodide ion symporter(NIS), antibodies to thyroid hormone, 
non specific auto antibodies against DNA are the some other thyroid 
auto antibodies. 
LEVELS OF THYROID AUTO ANTIBODIES 
TPO antibodies – less than 35 iu/ml is negative and more than 50 iu/ml is 
positive. 
                                       
TG antibodies – less than 225 iu/ml is negative and more than 325 iu/ml is 
positive. 
HISTOLOGICAL PICTURE 
• Mononuclear inflammatory infiltrates containing lymphocytes and 
plasma cells. 
• Germinal centers are well developed 
• Hurthle cells – atrophied thyroid follicle lined by epithelial cells 
containing abundant eosinophilic cytoplasm are seen. 
• Hurthle cells and heterogenous lymphocyte infiltration in an FNAC 
biopsy sample is diagnostic for hashimoto’s thyroiditis. 
CLINICAL COURSE 
The clinical presentation can be hypothyroid, euthyroid, or hyperthyroid. 
The most common clinical presentation is diffuse enlargement of the 
thyroid with features of hypothyroidism. 
Hashitoxicosis – in some cases the disruption of thyroid follicles produces 
secondary release of thyroid hormones and can result in a transient 
thyrotoxicosis. 
                                       
SYMPTOMS 
Symptoms due to decreased metabolic rate 
• Fatigue and weakness 
• Increased sensitivity to cold 
• Weight gain 
• Constipation 
• Cognitive dysfunction 
• Growth and mental retardation in children 
Symptoms due to protein accumulation 
• Dryness of skin, nails and hair 
• Hoarseness of voice 
• Facial puffiness 
• Peri orbital edema 
Other symptoms 
• Depression 
• Increased menstrual flow 
                                       
• Myalgia  
• Paraesthesia 
• Arthralgia 
• Pleural and pericardial effusions 
• Pubertal delay 
• Hearing abnormalities 
• Diastolic hypertension 
• Bradycardia 
• Delayed tendon reflex relaxation   
DIAGNOSIS 
• Thyroid function test(TFT) – estimation of serum values of TSH, 
free T3, free T4 can be used to find the clinical picture. 
• Anti TPO antibody - POSITIVE 
• FNAC – Presence of hurthle cells and lymphocytic infiltration.  
                                       
 
 
 
 
 
 
 
 
 
 
Diffuse goiter  hypothyroidism 
      Suspicion of auto 
immune thyroiditis 
      Investigate for anti 
thyroid peroxidase 
antibodies. 
positive negative 
Biopsy  
positive 
Diagnosis is 
confirmed 
                                       
      TREATMENT 
 If the patient presented with hypothyroidism, thyroxine 
replacement should be given. 
 If the patient presented with euthyroidism, prophylactic  thyroxine 
replacement should be given. 
 If the patient presented with sub clinical hypothyroidism,we look 
TSH value .if the TSH value >10mU/L we give low dose thyroxine 
[starting dose 25-50micro gram/day]. 
   INDICATIONS FOR SURGERY IN 
HASHIMOTO’S THYROIDITIS PATIENTS 
 Patients presented with tracheal compression     causing 
dyspnoea and esophageal compression causing dysphagia. 
 Dominant mass unresponsive to thyroxine therapy. 
 Increase in the size of the mass despite thyroxine therapy 
 
                                       
COMPLICATIONS 
• Diffuse goiter and hypothyroidism are the two primary 
complications of hashimoto’s thyroiditis. 
• Increased risk of other auto immune diseases like type 1 diabetes, 
autoimmune adrenalitis, rheumatoid arthritis, premature ovarian 
failure. 
• Thyroid lymphoma – a very rare complication. Can appear as a 
nodule. 
• Myxedema – can develop very rarely if hashimoto’s thyroiditis is 
left untreated. 
• Mental health issues like depression. 
• Cardiac problems due to increased cholesterol. 
• Hashimoto’s encephalopathy. 
HASHIMOTO’S ENCEPHALOPATHY 
It is a rare complication occuring in hashimoto’s thyroiditis. It is featured 
by a subacute onset of confusion which leads to delirium or dementia. 
The patient’s thyroid status may be euthyroid but  TPO antibodies are 
                                       
positive. Now a days the condition is also called steroid responsive 
encephalopathy with auto immune thyroiditis(SREAT). 
Clinical features 
• Memory loss 
• Seizures 
• Ataxia 
• Myoclonus 
Investigations to do are thyroid function test, TPO antibodies, EEG etc. 
MRI studies are usually normal but EEG shows non specific epileptiform 
discharges. CSF shows increased protein levels. 
In general hashimoto’s encephalopathy is a diagnosis of exclusion once 
psychiatric, infective, paraneoplastic, and vasculitic causes have been 
ruled out. 
TREATMENT 
The condition shows excellent positive response to high dose gluco 
corticoid therapy.  
 
                                       
ASSOCIATED CONDITIONS IN AUTO IMMUNE THYROIDITIS 
• Type 1 auto immune polyglandular syndrome – it include addison’s 
disease, hypoparathyroidism. 
• Type 2 auto immune polyglandular syndrome – type 1 diabetes 
mellitus, addison’s disease, lymphocytic hypophysitis, vitiligo, 
alopecia, celiac disease, pernicious anemia, myasthenia gravis, 
premature ovarian failure. 
• Rheumatological disorders such as rheumatoid arthritis, SLE, 
systemic sclerosis, sjogren’s syndrome. 
• Other conditions like auto immune thrombocytopenia, primary 
biliary cirrhosis, chronic active hepatitis can also occur with 
increased frequency in auto immune throiditis patients.  
 
 
 
 
                                       
 
 
 
 
 
 
   MATERIALS AND METHODS 
 
 
 
                                       
SELECTION OF PATIENTS 
 100 cases of thyroid disease patients are selected from which 40 
cases of auto immune thyroiditis patients are selected by using 
investigations like FNAC,TPO antibodies. 
INCLUSION CRITERIA   
 Clinical features and laboratory investigations proven thyroid disease 
patients . 
EXCLUSION CRITERIA 
 Patients with sick euthyroid syndrome 
 Patients with thyroid malignancy 
 Pregnant patients 
 
 
                                       
METHODOLOGY: 
 This study is a cross-sectional study wherein 100 thyroid disease 
patients satisfying inclusion and exclusion criteria are selected from 
endocrinology OPD at Stanley medical college and informed consent 
obtained for enrolment in this study.  
 Clinical features and laboratory investigations proven thyroid disease 
patients are selected wherein correlation of clinical and laboratory 
features like TFT,TPO-antibodies, cytology for these patients  to be 
ascertained for autoimmune thyroiditis 
 Statistics will be done for all data and suitable statistical tests of 
comparison will be done.  
 Continuous variables will be analyzed with the unpaired t-test and 
categorical variables will be analyzed with the chi-square test with 
Yates correction.  
 Statistical significance will be taken as P< 0.05.The data will be 
analyzed using   EpiInfo software (7.1.0.6version:Center for disease 
control, USA) and Microsoft Excel 2010. 
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            AGE AND SEX DISTRIBUTION 
AGE GROUP 
[YEARS] 
NO. OF FEMALE 
PATIENTS 
NO. OF MALE 
PATIENTS 
TOTAL NO. OF 
PATIENTS 
13-20 3 0 3 
21-30 20 1 21 
31-40 11 0 11 
41-50 3 1 4 
51-60 1 0 1 
                                       
 
 
 
 
 
 
 
 
                                       
 
 
 
 
            SEX DISTRIBUTION 
 
 
NO. OF FEMALE 
PATIENTS 
 
 
NO. OF MALE PATIENTS 
 
 
TOTAL NO. OF 
PATIENTS 
 
38 
 
2 
 
40 
 
                                       
 
 
Diffuse goiter
42.5%
Solitary nodular 
goiter
27.5%
Normal
17.5%
Multi nodular 
goiter
12.5%
CLINICAL PRESENTATION OF THE CASES 
 
 
 
 
 
 
                                       
   CLINICAL PRESENTATION OF CASES 
 
 
CLINICAL PRESENTATION 
  
NO. OF PATIENTS 
 
Diffuse goiter 
   
17 
 
Solitary nodular goiter 
   
11 
 
Multi nodular goiter 
  
 5 
 
Normal 
 
  7 
                                       
 
 
 
 
        
                                       
 
 
 THYROID PROFILE 
 
 
NO. OF PATIENTS 
 
 
 
 Hypothyroidism 
 
 
 
  19 
 
 
 
 Euthyroidism 
 
 
 
  19 
 
 
 
 Hyperthyroidism 
 
 
 
  2 
                                       
 
 
 
 
 
                                       
      CYTOLOGICAL FINDINGS ON FNAC 
 
 
 
   FNAC 
(Auto immune thyroiditis) 
 
 
 
 NO. OF PATIENTS 
 
 
 
  Positive 
     
 
 
    32 
 
 
 
 Negative 
     
 
 
       8 
                                       
 
 
 
 
 
 
 
                                       
TPO ANTIBODIES IN CASES STUDIED 
 
 
 
 
   TPO ANTIBODY 
 
 
 
 NO.OF PATIENTS 
 
 
 
 Positive 
 
 
 
   30 
 
 
 
 Negative 
 
 
 
   10 
 
                                       
CORRELATION BETWEEN CLINICAL PRESENTATION AND TPO ANTIBODY 
 
CLINICAL 
PRESENTATION 
                  TPO ANTIBODY  
TOTAL POSITIVE NEGATIVE 
NORMAL 7 0 7 
100.00% 0.00% 100.00% 
DIFFUSE GOITER 14 3 17 
82.40% 17.60% 100.00% 
SNG 9 2 11 
81.80% 18.20% 100.00% 
MNG 0 5 5 
0.00% 100.00% 100.00% 
TOTAL 30 10 40 
75.00% 25.00% 100.00% 
P VALUE 0 .001 
 
                                       
CLINICAL PRESENTATION AND TPO 
ANTIBODIES 
 In our study, there is significant correlation between clinical 
presentation and TPO antibodies present. 
 P-value=0.001 
 From this report ,TPO antibodies most commonly positive in     
the non goiter[Normal] patients followed by diffuse goiter 
then solitary nodular goiter, multi nodular goiter. 
                                       
  CORRELATION BETWEEN CLINICAL PRESENTATION AND FNAC 
  
CLINICAL 
PRESENTATION 
                       FNAC  
TOTAL POSITIVE NEGATIVE 
NORMAL 7 0 7 
100.00% 0.00% 100.00% 
DIFFUSE GOITER 17 0 17 
100.00% 0.00% 100.00% 
SNG 3 8 11 
27.30% 72.70% 100.00% 
MNG 5 0 5 
100.00% 0.00% 100.00% 
 TOTAL 32 8 40 
80.00% 20.00% 100.00% 
P VALUE 0.001 
 
                                       
CLINICAL PRESENTATION AND FNAC 
 In our study, there is significant correlation between 
clinical presentation and FNAC showing auto immune 
thyroiditis present. 
 P-value=0.001 
 From this report, FNAC showing auto immune thyroiditis 
most commonly positive in diffuse goiter, non 
goiter[Normal], multi nodular goiter followed by solitary 
nodular goiter. 
 
 
 
 
 
 
 
 
  
 
                                       
CORRELATION BETWEEN TPO ANTIBODY AND FNAC 
 
  
TPO ANTIBODY 
                          
                        FNAC   
 
 
 
TOTAL 
POSITIVE NEGATIVE 
POSITIVE 22 8 30 
73.30% 26.70% 100.00% 
NEGATIVE 10 0 10 
100.00% 0.00% 100.00% 
TOTAL 32 8 40 
80.00% 20.00% 100.00% 
P VALUE-0.068 
                                       
TPO ANTIBODIES AND FNAC 
 In our study shows no significant correlation between auto antibodies 
and cytological findings on FNAC. 
 P-value=0.068 
 Sarwat Fatima et al study showed significant correlation between auto 
antibodies and cytological findings on FNAC. 
                                       
 
 
 
 
 
 
    
   ANALYSIS AND DISCUSSION 
                                       
ANALYSIS AND DISCUSSION 
AGE DISTRIBUTION 
 In my study results shows autoimmune 
    thyroiditis more common in younger age group 
    mostly between 21-30yrs. 
 Similar findings observed in staii et al(2010) that study showed auto 
immune thyroiditis more common in younger age group(pre 
menopausal women)[11]. 
 kapila et al(1995) study showed auto immune thyroiditis more common 
in age group of  16-35years[12]. 
 Sarwat Fatima et al(2014) study showed auto immune thyroiditis more 
common in age group of 21-30 years. 
 
 
                                       
SEX DISTRIBUTION 
 In our study, auto immune thyroiditis mostly affect  females. 
 Staii et al(2010) study showed auto immune thyroiditis more common in 
females(11). 
 Kapila et al(1995) study showed auto immune thyroiditis more common 
in females(12). 
 Sarwat Fatima et al(2014) study showed auto immune thyroiditis more 
common in females. 
 
Clinical presentation 
 In our study , diffuse goiter is most common  presentation 
followed by solitary nodule thyroid then multi nodular goiter. 
 Kapila et al study showed auto immune thyroiditis most 
commonly present as a diffuse goiter followed by solitary nodule 
thyroid then multi nodular goiter(12). 
                                       
 Sarwat Fatima et al study showed auto immune thyroiditis most 
commonly present as a diffuse goiter followed by solitary nodule 
thyroid then multi nodular goiter(20). 
 
THYROID PROFILE  
 In our study, the most common thyroid profile is hypothyroidism 
followed by euthyroidism then hyperthyroidism. 
 Kapila et al study showed the most common presentation was 
euthyroidism(12) 
 Sarwat fatima et al study showed  the most common presentation 
hypothyroidism followed by euthyroidism(20) 
 Esbeih A T et al( 17) study showed the most common presentation 
euthyroidism. 
 
 
 
                                       
CLINICAL PRESENTATION AND TPO 
ANTIBODIES 
 In our study, there is significant correlation between clinical 
presentation and TPO antibodies present. 
 P-value=0.001 
 From this report ,TPO antibodies most commonly positive in 
the non goiter[Normal] patients followed by diffuse goiter 
then solitary nodular goiter, multi nodular goiter. 
    CLINICAL PRESENTATION AND FNAC 
 In our study, there is significant correlation between 
clinical presentation and FNAC showing auto immune 
thyroiditis present. 
 P-value=0.001 
 From this report, FNAC showing auto immune thyroditis 
most commonly positive in diffuse goiter, non 
goiter[Normal],multi nodular goiter followed by solitary 
nodular goiter. 
                                       
TPO ANTIBODIES AND FNAC 
 In our study, no significant correlation between auto antibodies and 
cytological findings on FNAC. 
 P-value=0.068 
 Sarwat fatima et al study showed significant correlation between auto 
antibodies and cytological findings on FNAC. 
 
 
 
 
 
 
 
 
 
 
 
 
                                       
 
 
 
 
 
              
              CONCLUSION 
 
 
 
 
                                       
CONCLUSION 
 From this study ,we know  auto immune thyroiditis  more 
commonly affect younger age group. 
 Auto immune thyroiditis more commonly affect  females. 
 Auto immune thyroiditis most commonly present as a diffuse 
goiter followed by solitary nodular goiter then multi nodular 
goiter. 
 Auto immune thyroiditis most commonly present as a 
hypothyroidism followed by euthyroidism then hyperthyroidism. 
 There is significant correlation between TPO antibodies positivity 
and clinical presentation. TPO antibodies most commonly positive 
in the non goiter[Normal] patients followed by diffuse goiter then 
solitary nodular goiter, multi nodular goiter. 
 There is significant correlation between FNAC showing auto 
immune thyroiditis and clinical presentation.  
                                       
 FNAC showing auto immune thyroiditis most commonly positive in 
diffuse goiter, non goiter[Normal], multi nodular goiter followed 
by solitary nodular goiter. 
 There is no significant correlation between auto antibodies levels 
and cytological findings on FNAC. 
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             ANNEXURE 
 
 
 
                                       
      STUDY ON CLINICAL,SEROLOGICAL,  
   CYTOLOGICAL CORRELATION IN CASES 
OF AUTOIMMUNE THYROIDITIS                                                 
 
                                             PROFORMA 
 
NAME:                                                  AGE:   SEX: 1.M    2.F 
 
ADDRESS:                                                                         CONTACT NO: 
 
OCCUPATION   :  
 
 
 
                                       
HISTORY 
H/O  Hyperactivity, irritability                                                 YES/NO
  
H/O  Heat intolerance and sweating                                         YES/NO 
 
H/O  Palpitations                                                                       YES/NO 
 
H/O  Fatigue and weakness                                                     YES/NO 
 
H/O  Weight loss with increased appetite                                 YES/NO 
 
H/O  Diarrhea                                                                            YES/NO 
 
H/O  Oligomenorrhea, loss of libido                                          YES/NO 
H/O  Dry skin                                                                            YES/NO 
H/O  Feeling cold                                                                     YES/NO 
 
H/O  Hair loss                                                                           YES/NO 
 
H/O Difficulty concentrating and poor memory                         YES/NO 
                                       
 
H/O  Constipation       YES/NO 
 
H/O Weight gain with poor appetite       YES/NO 
 
H/O Dyspnea       YES/NO 
 
H/O Hoarse voice       YES/NO 
  
H/O  Menorrhagia              YES/NO 
 
H/O  Paresthesia                                                                      YES/NO 
 
H/O  Impaired hearing            YES/NO 
 
 RELEVENT CLINICAL EXAMINATION 
Tachycardia          YES/NO 
 
Tremor         YES/NO 
  
                                       
Goiter        YES/NO 
 
Warm, moist skin       YES/NO 
 
Muscle weakness, proximal myopathy      YES/NO 
 
Lid retraction or lag                                                                YES/NO 
 
Gynecomastia      YES/NO 
 
Dry coarse skin; cool peripheral extremities      YES/NO 
 
Puffy face, hands, and feet (myxedema)      YES/NO 
  
Diffuse alopecia      YES/NO 
 
Bradycardia      YES/NO 
 
Peripheral edema       YES/NO 
   
 
                                       
INVESTIGATIONS 
 THYROID FUNCTION TEST 
          TSH 
          FREE T3 
          FREE T4 
 TPO-ANTIBODIES 
 FNAC                                                                                     
 
 
 
 
 
 
 
 
 
                                       
                                   INFORMED CONSENT 
Govt. Stanley medical college, chennai – 600001 
                             Informed consent 
  Study on clinical,serological, cytological correlation in cases of  
  autoimmune thyroiditis 
 
Place of study:  govt. Stanley medical college, Chennai 
 
I ……………………………………………. have been informed about the 
details of the study in my own language. 
I have completely understood the details of the study. 
I am aware of the possible risks and benefits, while taking part in the study. 
I understand that I can withdraw from the study at any point of time and even 
then, I can receive the medical treatment as usual. 
I understand that I will not get any money for taking part in the study. 
I will not object if the results of this study are getting published in any 
medical journal, provided my personal identity is not revealed. 
I know what I am supposed to do by taking part in this study and I assure 
that I would extend my full cooperation for this study. 
 
 
 
Volunteer:       Witness: 
Name and address                  Name and address 
Signature/thumb impression:  Signature/thumb   impression 
Date:        Date: 
 
 
Investigator 
Signature and date 
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